基于网络药理学及实验验证探讨罗布麻叶-钩藤药对治疗高血压病的作用机制
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R285

基金项目:

国家自然科学基金面上项目(82273907);江苏省中医药科技发展计划项目(YB201938)


Mechanism of Apocyni Veneti Folium-Uncariae Ramulus Cum Uncis in Treating Hypertension Based on Network Pharmacology and Experimental Verification
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:利用网络药理学及实验验证的方法探讨罗布麻叶-钩藤药对治疗高血压病的作用机制。方 法:使用中药系统药理学数据库与分析平台(TCMSP) 数据库,筛选罗布麻叶-钩藤主要化学成分和作用靶 点,高血压病疾病靶点通过GeneCards、在线人类孟德尔遗传数据库(OMIM) 查询,将罗布麻叶-钩藤的作用 靶点与疾病靶点交集得到罗布麻叶-钩藤药对治疗高血压病的共同靶点,将共同靶点导入STRING 数据库构建 蛋白-蛋白相互作用(PPI) 网络。将共同靶点导入DAVID 在线数据库进行基因本体(GO) 与京都基因与基因 组百科全书(KEGG) 富集分析,使用AutoDock 和PyMOL 进行分子对接和可视化。采用两肾一夹法建立高血 压病大鼠模型,治疗组大鼠给予罗布麻叶-钩藤药液连续灌胃2 周,模型组与空白组给予等体积0.9%氯化钠溶 液连续灌胃2 周。比较3 组收缩压(SBP)、胸主动脉病理结构及炎症指标水平。结果:筛选后得出罗布麻叶 的活性成分6 个,钩藤的活性成分33 个,罗布麻叶-钩藤药对治疗高血压病的靶点152 个,包括肿瘤坏死因 子(TNF) -α、白细胞介素(IL) -6、IL-1β、IL-8、IL-4、IL-1α、IL-2、IL-10、趋化因子配体2(CCL2)、 细胞间黏附分子-1(ICAM1) 等。KEGG 富集分析共得到TNF 信号通路、缺氧诱导因子-1(HIF-1) 信号通 路、Toll 样受体(TRL) 信号通路等122 条信号通路。分子对接结果显示,山柰酚和槲皮素与TNF、CCL2 和 IL-8 等结合较好。实验结果显示罗布麻叶-钩藤药对显著降低了高血压病大鼠的血压,有效改善了高血压病大 鼠胸主动脉的病理组织结构,降低了高血压病大鼠血清IL-6、IL-10、IL-1β、TNF-α 水平。结论:罗布麻叶- 钩藤药对可通过多成分、多靶点、多通路治疗高血压病。

    Abstract:

    Abstract: Objective: To explore the mechanism of Apocyni Veneti Folium- Uncariae Ramulus Cum Uncis in treating hypertension based on network pharmacology and experimental verification. Methods:The main chemical components and action targets of Apocyni Veneti Folium-Uncariae Ramulus Cum Uncis were screened by Traditional Chinese Medicine Systems Pharmacology Platform (TCMSP). The targets of hypertension were investigated by Gene Cards and Online Mendelian Inheritance in Man (OMIM). The common targets for treating hypertension were obtained by intersecting the action targets of Apocyni Veneti Folium-Uncariae Ramulus Cum Uncis and the disease targets. The common targets were imported into the STRING database to construct the protein- protein interaction (PPI) network. The common targets were imported into the DAVID online database for gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, and AutoDock and PyMOL were used for molecular docking and visualization. Model rats with hypertension were established by two-kidney and one-clip method. The rats in the treatment group were given solution of Apocyni Veneti Folium- Uncariae Ramulus Cum Uncis by gavage for two weeks, and the rats in the model group and the blank group were given 0.9% sodium chloride solution by gavage for two weeks. The systolic blood pressure (SBP), pathological structure of thoracic aorta and inflammatory indexes were compared between the three groups. Results: After screening, 6 active components of Apocyni Veneti Folium, 33 active components of Uncariae Ramulus Cum Uncis,and 152 targets of Apocyni Veneti Folium-Uncariae Ramulus Cum Uncis in treating hypertension were obtained,including tumor necrosis factor (TNF)-α,interleukin (IL)-6,IL-1β,IL-8,IL-4,IL-1α, IL-2,IL-10,chemokine C-C motif ligand 2 (CCL2) and intercellular cell adhesion molecule-1 (ICAM1). A total of 122 signaling pathways including TNF signaling pathway , hypoxia-inducible factor- 1 (HIF- 1) signaling pathway and Toll- like receptor (TRL) signaling pathway were obtained by KEGG enrichment analysis. Molecular docking results showed that kaempferol and quercetin were well bound to TNF,CCL2 and IL- 8. The experimental results showed that Apocyni Veneti Folium- Uncariae Ramulus Cum Uncis significantly reduced the blood pressure of rats with hypertension, effectively improved the pathological structure of thoracic aorta,and reduced the levels of serum IL-6,IL-10,IL-1β and TNF-α. Conclusion: Apocyni Veneti Folium-Uncariae Ramulus Cum Uncis can treat hypertension by multi-component,multitarget and multi-pathway.

    参考文献
    相似文献
    引证文献
引用本文

李东娜,司香环,李宏佳,徐天舒.基于网络药理学及实验验证探讨罗布麻叶-钩藤药对治疗高血压病的作用机制[J].新中医,2024,56(2):177-185

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-01-25
  • 出版日期: